| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 40.856 | 16.790 | 80.357 | 173.459 | 605.923 | 547.621 | 497.132 | 695.072 | 1.081.981 | 1.057.099 |
| Total Income - EUR | 40.898 | 17.425 | 80.634 | 176.523 | 620.502 | 558.121 | 503.344 | 713.024 | 1.087.761 | 1.062.184 |
| Total Expenses - EUR | 38.700 | 12.971 | 68.791 | 106.178 | 428.249 | 405.288 | 344.201 | 508.100 | 788.645 | 834.691 |
| Gross Profit/Loss - EUR | 2.198 | 4.453 | 11.843 | 70.345 | 192.252 | 152.833 | 159.143 | 204.924 | 299.116 | 227.493 |
| Net Profit/Loss - EUR | 972 | 3.950 | 9.432 | 65.116 | 186.171 | 147.788 | 155.016 | 199.511 | 262.954 | 188.086 |
| Employees | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 2 | 2 | 3 |
Check the financial reports for the company - Nutraceutical & Cosmetics S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 60 | 0 | 0 | 138 | 1.774 | 1.546 | 1.321 | 1.135 | 941 | 186.662 |
| Current Assets | 12.076 | 15.391 | 21.304 | 83.848 | 346.948 | 192.884 | 164.287 | 541.851 | 473.177 | 271.664 |
| Inventories | 0 | 0 | 0 | 0 | 47.545 | 20.799 | 35.150 | 66.487 | 177.457 | 94.215 |
| Receivables | 187 | 5 | 211 | 307 | 11.419 | 1.222 | 35 | 225.371 | 118.640 | 0 |
| Cash | 11.889 | 15.386 | 21.093 | 83.541 | 287.984 | 170.863 | 129.102 | 249.993 | 177.080 | 177.448 |
| Shareholders Funds | 1.017 | 4.956 | 9.484 | 65.168 | 207.931 | 147.838 | 155.191 | 199.855 | 291.627 | 188.428 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 61 | 61 | 61 | 60 |
| Debts | 11.119 | 10.434 | 11.819 | 18.819 | 140.791 | 46.592 | 10.501 | 343.205 | 182.556 | 269.953 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4690 - 4690" | |||||||||
| CAEN Financial Year |
4690
|
|||||||||
Comments - Nutraceutical & Cosmetics S.r.l.